U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

PITTSBURGH, July 2, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Division of the U.S. Department of Justice (“DOJ”) has advised that it no longer considers Mylan, and its former President, Rajiv Malik, a subject of its antitrust investigation in the…